Biosimilar Insights
-
The Future Of QC: Robotics And Automation
5/13/2025
See how pharma 4.0 is revolutionizing the pharmaceutical industry with automation and digitalization to transform microbiological quality control labs into efficient, real-time-monitored environments that enhance productivity.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing
5/12/2025
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
Perfusion Cell Line Development For Intensified Processes
5/5/2025
The biopharmaceutical industry is transforming by shifting to continuous and intensified upstream bioprocesses, which are driven by evolving demands. Discover the key goals and innovations shaping this transition for modern healthcare.
-
What Is The Position Of Regulatory Authorities On PUPSIT?
5/2/2025
PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.
-
How Robotic Isolator Technology Aligns To Annex 1 Principles
4/28/2025
Robotic gloveless isolators provide exceptional automation to eliminate human intervention and reduce contamination risk. Discover how they ensure compliance with the EU Annex 1 guideline to enhance sterility, precision, and monitoring.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
4/28/2025
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Biofluorescent Particle Counters Are Gaining Momentum
4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
-
CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics
4/28/2025
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
White Raven's Accelerated Path To GMP Certification
4/28/2025
CDMO White Raven achieved GMP certification using an innovative aseptic filling solution in just 18 months. Discover how meticulous planning and collaboration set a new industry standard for efficiency.
-
Service Solutions Designed To Help You Gain Speed To Clinic And Market
4/28/2025
Discover how speed, cost, and regulatory acceptance impact drug manufacturing, as well as learn about aseptic filling challenges and how innovative services can enhance your efficiency and compliance.